- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
AstraZeneca reported optimistic results for its lung cancer drug Tagrisso in a trial, saying it improved progression-free survival by nearly six months.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
A sale or spinoff of this business will likely get the attention of competitors that want to increase their over-the-counter product units.